Biomedical Engineering Reference
In-Depth Information
4
14
3.5
12
3
10
2.5
8
2
6
1.5
4
1
2
0.5
1
1.2
1.4
1.6
1.8
2
2.3
2.4
2.5 2.6
Fractal dimension,
D
f2
2.7
2.8
F
G
Fractal dimension,
D
f1
0.4
2.6
2.4
0.35
2.2
0.3
2
0.25
1.8
0.2
1.6
0.15
1.4
1.77
1.78
1.79
Fractal dimension,
D
fd
1.8
1.81
1.82
1.83
1.84
0
1
2 3
Con A concentration (nM)
4
5
H
I
1
10
9
0.9
8
0.8
7
0.7
6
0.6
5
0.5
4
0
1
2
3
4
5
0.5
0.6
0.7
0.8
0.9
1
J
K
Figure 12.10—cont'd
(f) Increase in the binding rate coefficient, k
1
, with an increase in the fractal dimension, D
f1
.
(g) Increase in the binding rate coefficient, k
2
, with an increase in the fractal dimension, D
f2
.
(h) Increase in the dissociation rate coefficient, k
d
, with an increase in the fractal dimension for
dissociation, D
fd
. (i) Decrease in the ratio of the fractal dimensions, D
f2
/D
f1
, with an increase in the
Con A concentration in solution. (j) Increase in the ratio of the fractal dimensions, D
f1
/D
fd
, with an
increase in the Con A concentration in solution. (k) Increase in the affinity, K
1
(
Con A concentration (nM)
D
f1
/
D
fd
¼
k
1
/k
d
), with an
increase in the ratio of fractal dimensions, D
f1
/D
fd
.
continued